未登录
分享
收藏
分享
收藏MRI monitoring of avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer
Preda, A; Novikov, V; Möglich, M; Turetschek, K; Shames, DM; Brasch, RC; Cavagna, FM; Roberts, TPL
分享
收藏
分享
收藏
分享
收藏Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: Initial phase II multicenter trial
Daldrup-Link, HE; Rydland, J; Helbich, TH; Bjornerud, A; Turetschek, K; Kvistad, KA; Kaindl, E; Link, TM; Staudacher, K; Shames, D; Brasch, RC; Haraldseth, O; Rummeny, EJ
分享
收藏MRI monitoring of tumor response following anglogenesis inhibition in an experimental human breast cancer model
Turetschek, K; Preda, A; Floyd, E; Shames, DM; Novikov, V; Roberts, TPL; Wood, JM; Fu, YJ; Carter, WO; Brasch, RC
分享
收藏MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model
Turetschek, K; Preda, A; Floyd, E; Shames, DM; Novikov, V; Roberts, TPL; Wood, JM; Fu, YJ; Carter, WO; Brasch, RC
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏